Express Scripts Earnings Call, Fourth Quarter 2007
10th June 2008 00:00 AM |
|
| Business fundamentals remain strong as the firm is well-positioned in for delivering superior value to clients and superior growth for stockholders. |
|
| The provider of integrated PBM servives reported earnings of $139 million or 70 cents a share, down 6% from $147 million or 52 cents a share last year despite sales rising 4% driven by the execution of the business model, which resulted generic utilization and lower drug purchasing costs. Express Scripts generated cash flow of $827.3 million compared to $658.6 million last year. |
|
|
Full Story... |
Express Scripts Fourth Quarter Earnings Call
5th March 2008 00:00 AM |
|
| The earnings dropped from $147.2 million or 54 cents per share in previous year to $138.6 million or 54 cents per share. |
|
| The provider of pharmacy benefit management services reported revenue of $4.69 billion, an increase of 4% from $4.5 billion in the prior year. The company is reviewing the strategic fit of the infusion business in its product portfolio and is in the process of selling this business unit. During 2007, Express Scripts repurchased 23.1 million shares of its common stock for a total cost of over $1.1 billion. For fiscal 2008, the firm projects EPS in the range of $2.92 to $3. |
|
|
Full Story... |
|
|
